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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S88summed K&L grades between baseline and 5 years were 0, 1.5-3.0, 3.0-5.5,
and 5.5-17.5 for 39.0, 18.3, 22.5, and 20.1% of participants, respectively.
pLeptin was positively associated with pResistin (stand beta 0.115,
P¼0.000) and negatively with pAdiponectin (stand beta -0.080, P¼0.012),
other associations between adipokines were not statistically signiﬁcant.
pLeptin showed statistically signiﬁcant associations with sPIIANP and
sPIIINP (stand betas 0.050, P¼0.01 and 0.056, P¼0.005, adjusted for age,
BMI, and gender). pLeptin showed a statistically signiﬁcant association
with OA progression before adjustment (stand beta 0.099, P¼0.007), that
turned non-signiﬁcant after adjustment for demographic variables (stand
beta -0.006, P¼0.917).
pAdiponectin was statistically signiﬁcantly associated with sCOMP only
(stand beta 0.105, P¼0.001, adjusted) and not associated with OA burden
and progression (data not shown).
pResistin showed a statistically signiﬁcant associationwith sPIIINP, sCOMP,
and sC12C (stand betas 0.091, -0.083, and -0.086, respectively, P<0.014)
and was associated with radiographic OA burden (stand beta 0.093,
P¼0.008, adjusted) and progression (in binary logistic regression: (Exp(B)
1.165, P¼0.031, adjusted for age, gender, BMI, and baseline summed K&L
grade. Multiple linear regression: stand beta 0.011, P¼0.769, adjusted).
Conclusions: Leptin and resistin showed the most associations with
biomarkers and radiographic OA burden and progression. Leptin may
function as a humoral mediator between OA progression and demo-
graphics, while resistin also showed an effect on OA burden and
progression apart from the studied demographics. The low grade of all
associations may be partly due to the limitations of biomarkers and
radiographic disease measures in early-stage OA. Nevertheless, these data
indicate that systemic adipokines could be involved in early-stage OA
burden and progression.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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COMPARISON OF HEALTHY AND NORMATIVE AGING REVEALS
A METABOLIC COMPONENT IN HAND OA AND OA BIOCHEMICAL
MARKER PROFILES.
S.D. Bos 1,2, M. Beekman 1, R. Westendorp 1, T. de Craen 1,
M. Kloppenburg 1, I. Meulenbelt 1,2, P.E. Slagboom1,2. 1 LUMC, Leiden,
NETHERLANDS; 2 The Netherlands Genomics Initiative-sponsored
Netherlands Consortium for Hlth.y Aging, Leiden, NETHERLANDS
Purpose: Epidemiological studies have shown associations between
osteoarthritis (OA) and age, as well as between OA and metabolism, which
are not completely understood. It can be questioned whether intrinsic
metabolic programming affects OA risk and circulating levels of
biochemical markers applied in OA research such as COMP and CTX2.
These biomarkers measured in serum and urine reﬂect cartilage turnover
and degradation, respectively.
Insight in interactions between age, metabolism and OA will allow for
better clinical classiﬁcation of patients and for a more reliable assessment
of disease activity or progression using biochemical markers. Such insights
may be obtained from studies focused on aging and metabolism, inde-
pendent of disease. To such end, we have analyzed levels of serum COMP
and urinary CTX2 and hand radiographic OA (ROA) scores in healthy aging
subjects from long-lived families, their partners as population controls and
OA patients. We analyzed age related aspects of the biochemical markers
and hand ROA scores and compared the marker and ROA score proﬁles in
healthy and normative aging and in disease. Next we tested whether
glucose levels inﬂuenced the levels of biochemical markers and hand ROA
scores in the healthy and normative aging subjects.
Methods: The Leiden Longevity Study (LLS) consists of long-lived siblings,
their offspring and partners of the offspring as controls. In middle age the
familial longevity trait is reﬂected by a 30% increased survival, low prev-
alence of metabolic disease and healthy metabolic proﬁle (such as lower
glucose levels). We measured uCTX2 and sCOMP levels in a subset of the
females of the LLS (N¼151 healthy agers and N¼181 controls) and scored
hand radiographs (20 joint sites) according to Kellgren and Lawrence
(N¼107 healthy agers and N¼128 controls). The same scores were avail-
able for the OA affected females of the GARP study (N¼315). Furthermore,
these were previously typed for the biochemical marker levels sCOMP anduCTX2. Linear mixed models were applied testing for relationships
between age and hand ROA data or marker levels, whilst correcting for
BMI, familial dependencies and potential batch effects between the GARP
and LLS study.
Results: sCOMP shows a comparable age related increase in healthy and
normative agers as well as in OA patients. Healthy agers, however, had
a signiﬁcantly higher mean sCOMP level as compared to the controls.
Remarkably, uCTX2 levels showed no increase with age in healthy agers
whereas a signiﬁcant and equal age related increase was observed
amongst the controls and OA patients.
Healthy ageing women have the lowest age related increase of hand ROA
score, whereas this has a signiﬁcant linear increase via controls to the OA
patients (study groups coded as 0, 1 and 2 for healthy agers, controls and
GARP patients respectively, BMI and age adjusted). When we additionally
selected the healthy agers with glucose levels below the median within
their group, the interaction of study group with hand ROA scores became
more pronounced between healthy agers and controls.
Conclusions: When interpreting OA biomarkers, age is a major factor to
consider. Furthermore, a healthy aging metabolic proﬁle as reported for
the Leiden longevity family members associated to a lower age-related
increase in hand ROA scores and uCTX2 levels as compared to controls.
This may indicate that metabolic health should also be considered in the
assessment of the risk for hand ROA onset and monitoring of progression
on the basis of these biomarkers.
Comp as a new potential biomarker for osteoarthritis.
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20KDa FRAGMENT OF OSTEOGLYCIN: AN INNOVATIVE TOOL FOR OA
PATIENTS CHARACTERIZATION
A. Farran, L. Tio, P. Benito, J. Monfort. IMIM-Hosp. del Mar, Barcelona, Spain
Purpose: Osteoarthritis is the most common rheumatologic disease and is
characterized by increased protease activity resulting in cartilage degra-
dation. Nowadays, radiographic measures are the traditional study for
diagnosis, but the abnormal metabolic process begins in the articular
cartilage several years before destruction of the tissue can be detected
radiologically. Our aim in this study is the search for new osteoarthritic
molecular biomarkers, by the screening of different ECM proteins and their
fragments in osteoarthritic (OA) and normal cartilage (CT).
Methods: Normal samples were obtained from femoral cartilage of
patients who underwent hip replacement due to osteoporotic fracture. OA
cartilage samples came from knee and hip arthrosic patients undergoing
arthroplasty. ECM proteins from these samples were extracted using
Guanidinium chloride (4 mol/l) method. After the extraction, proteins and
glycosaminoglycans (GAG's) were quantiﬁed by Bradford and dimethyl-
methylene-blue (DMB) assay respectively. Proteoglycans studied from the
ECM protein extracts of knee and hip cartilage were normalized by Brad-
ford concentration and analyzed by Western blotting. The bands intensity
was quantiﬁed by Quantity One software. In order to study the activity of
the protease in front of each proteoglycan studied and to ﬁnd out speciﬁc
fragments from OA patients, the extracts were digested with recombinant
matrix metalloproteinase 13 (MMP-13) at 2, 4, 6, 8, 16 and 24h and
analyzed with western blot.
Results: Osteoglycin (OGN), Matrilin3 (MATN3), and Cartilage oligomeric
matrix protein (COMP) were identiﬁed by Western Blotting. Our results
showed that MATN3 expression did not present any difference between
CT, OA hip and OA knee cartilage.
We could observe digestion of MATN3 by MMP-13 after 6 hours of incu-
bation and it was nearly completely digested at 24h.
In the case of COMP expression, the analysis showed a different band
pattern in OA knee samples compared with CT and OA femoral samples.
Interestingly, a COMP fragment of approximately 60 KDa was observed at
16h and 24h of incubation in all the samples.
Regarding the OGN results, we surprisingly found that it was more
abundant in OA knee samples than in CT ones, contrary to other previously
described proteoglycans observations. Concerning to OGN digestion, we
could also see differences between samples; while OGN from CT samples
was completely digested at 16h, OGN from OA femoral samples showed
still a weak band at 16h of digestion that was completely digested at 24h.
Finally, in OA knee samples, at 24 hours the digestions was not still
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S89complete. Furthermore, about 30% of OA samples (hip and knee) showed
a fragment of approximately 20KDa that it's not present in none of the 18
control samples analyzed. This fragment seems not to be speciﬁc of
MMP13 since it was present before the incubation with the protease, and
the intensity of the band did not increase with the in vitro MMP-13
digestion.
Conclusions: We found three ECM proteins susceptible of MMP13 diges-
tion that could be potential OA biomarkers. Interestingly, results showed
that 30% of OA patients had a MMP13 not speciﬁc fragment from OGN. The
presence or absence of this fragment could be useful as a tool to identify
a group of patients with similar characteristics
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ANALYSIS OF THE SERUM BIOMARKERS IN HUMAN KNEE
OSTEOARTHRITIS
C. Daozhang, C. Yuxian, Z. Hua. The third afﬁliated Hosp. of Sun Yat-Sen
Univ., guangzhou, China
Purpose: Osteoarthritis (OA) is characterized by a degeneration of carti-
lage whose main clinical symptoms are pain, deformity and loss of func-
tion.With the coming of global aging society, OA has become a leading
cause of disability in the elderly.Its poorly understood pathogenesis limits
the discovery of targets for pharmacological intervention and there are few
effective medical treatments beyond pain control and surgery. Effective
method of early diagnosis and treatment of OA are desperately needed.
To search proteins that might serve as serum biomarkers for OA diagnosis,
treatment or pathogenesis, this study preformed technologies to identify
differentially expressed proteins from serum obtained from patients with
knee osteoarthritis(OA) and controls.
Methods: There are 4 subjects of OA and 4 age- and sex- matched normal
adults involved in the study, 4 subjects of OA are randomly selected from30
patients diagnosed with primary knee osteoarthritis. Serum samples from
each subject were treated with ProteoExtract Albumin/IgG Removal Kit
and Clean-up Kit, then cross-labeled with different CyDye, followed by two
dimension difference in gel electrophoresis(2D-DIGE), map scanning, and
then themaps of protein spots were compared using the software DeCyder
v6.0 to ﬁnd out the different expressed proteins. Treat these proteins with
Matrix assisted laser desorption ionization-time of ﬂight mass spec-
trometry(MALDI-TOF-MS), and get peptide ﬁnger printing maps(FPM),
then search themwithMASCOT in Swiss-Prot/Uniprot date base to identify
these proteins. Finally, use bioinformatics to analysis biological functions
and research value of these proteins.
Results: We found 14 differentially expressed protein spots compared
serum samples from patients with OA relative to the controls. The MS
revealed 14 proteins that alpha-2-macroglobulin, gelsolin, vitamin K-
dependent protein S, kininogen-1, complement C3 were increased, and
haptoglobin, inter-alpha-trypsin inhibitor heavy chain H4(ITIH4), apoli-
poprotein E were decreased in OA serum samples. Alpha-2-macroglobulin,
ITIH4, kininogen-1 were related to the body's inﬂammatory reaction,
vitamin K-dependent protein S, apolipoprotein E were involved in cell
apoptosis , and alpha-2-macroglobulin, complement C3 participated in
immune response. Some studies indicated that alpha-2-macroglobulin is
related to the degradation of cartilage extracellular matrix. Some studies
found that alpha-2-macroglobulin, apolipoprotein E, Complement 3, gel-
solin, haptoglobin and kininogen-1 appearanced in synovial [[Unsup-
ported Character - ﬂ]]uid, and apolipoprotein E, alpha- 2-macroglobulin,
haptoglobin increased in synovial [[Unsupported Character - ﬂ]]uid from
OA compared with the health controls.
Conclusions: 1,This study successfully settled the serum comparative
proteomics technique of OA, combined the 2D-DIGE and MALDI-TOF-MS,
which provided a valuable method for screening and identiﬁcation of
disease related proteins; 2,This study found that alpha-2-macroglobulin,
gelsolin, vitamin K-dependent protein S, kininogen-1, complement C3
were increased, and haptoglobin, inter-alpha-trypsin inhibitor heavy chain
H4(ITIH4), apolipoprotein E were decreased in OA serum samples. 3,The
result of bioinformatics analysis indicated that the pathogenesis of oste-
oarthritis might be related to inﬂammation, immune or cell apoptosis;
4,Alpha-2-macroglobulin,apolipoprotein E,complement C3,gelso-
lin,haptoglobin,kininogen-1 might be utilized as potential biomarkers fordiagnosis or treatment of OA, they also provided the new clues for the
future study of the OA pathogenesis.
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356-373 ELISA, A MORE SENSITIVE SANDWICH ASSAY FOR DETECTING
AGGRECAN FRAGMENTS CLEAVED BY ADATMSS AT 373-374 SITE, IS
A POTENTIAL BIOMARKER FOR HUMAN JOINT DISEASES.
B. Wang 1, A.-C.B. Jensen 1, K.T. Ngo 1, Y. Ding 2, P. Chen 1, M.A. Karsdal 1,
Q. Zheng 2, P. Qvist 1. 1Nordic BioSci., Copenhagen, DENMARK; 2Nordic
BioSci. Beijing, Beijing, China
Purpose: Aggrecan degradation is believed to be a crucial process in joint
diseases such as OA and RA. The ADAMTSs cleavage site TEGE373-
374ARGS is a hot spot for investigation of aggrecan degradation. We have
developed a competitive ELISA AGNx1 for detecting fragments containing
neo-epitope NITEGE373, and a sandwich ELISA G1-373 for detecting
fragment containing both NITEGE373 and an epitope located in G1/G2
domain of aggrecan. There are disadvantages for the existing ELISAs:
lower sensitivity for the fragment in serum samples and unsatisﬁed
technical performance result for G1-373 with higher coefﬁcient of vari-
ation (CV) variation.
The aim of this study was to develop a sandwich ELISA 356-373 with
higher sensitivity detecting fragments containing NITEGE373.The ELISAs
were characterized and compared by using the Full Depth Cartilage (FDC)
explant culture model.
Methods: Full depth bovine cartilage (FDC) including all subpopulations of
chondrocytes from superﬁcial zone to the deep zone of the cartilage
explants was obtained from the joint of one to two-year- old calf. The
pieces (20-25mg) were placed in 96-well plate and incubate for 21 days at
37C with 5% CO2. Serum freemedium containing oncostatin M and tumor
necrosis factor (TNF) alpha were replaced every second or third day and
store at -20C before analysis by: (1) competitive NITEGE373 ELISA
(AGNx1) detecting aggrecan fragments containing neo-epitope
NITEGE373, (2) sandwich G1-373 ELISA detecting aggrecan fragments
containing both neo-epitope NITEGE373 and G1 domain, (3) sandwich
356-373 ELISA detecting fragments containing both neo-epitope
NITEGE373 and epitope 352TVQTVTW358 in interglobular domain (IGD).
Results: We found that: (1) aggrecanase-derived aggrecan fragments
containing NITEGE373 were dose-dependently released in the early (day
2-7 of culturing) and mid phase (day 9-14) into the supernatant from FDC
explants stimulated with catabolic cytokines. (2) The fragments released,
proﬁled by the three assays, were similar but different: the NITEGE373
competitive ELISA and the 356-373 sandwich ELISA showed two peak
releases. The G1-373 sandwich ELISA only showed one release. (3) The
release of NITEGE373 fragments detected by NITEGE373 competitive ELISA
or the 356-373 sandwich ELISA was delayed by MMPs inhibitor GM6001,
whereas the fragments release detected with G1-373 sandwich ELISA was
partially but signiﬁcantly inhibited by GM6001 (33% inhibition), indicating
that MMPs are involved in G1-373 ELISA-detecting fragment derivation.
(4) Higher sensitivity and better technical performance data was achieved
for the 356-373 ELISA compared to NITEGE373 competitive ELISA and G1-
373 ELISA, respectively. (5) 356-373 ELISA could be applied for human
samples testing with good dilution recovery, indicating its further poten-
tial clinical application for joint diseases as a biomarker.
Conclusions: We developed a new sandwich ELISA detecting the
ADAMTSs derived fragments containing neo-epitope NITEGE373 and
another epitope 352TVQTVTW358 in IGD. This ELISA is more sensitive
than the previous competitive NITEGE373 ELISA which are lack of sensi-
tivity for human samples test, and more technically robust than the G1-
373 ELISA which has weak stability. Its clinical application, i.e., patient
samples detection, will be investigated in the coming future.
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THE IDENTIFICATION AND DEVELOPMENT OF COMPETITION ELISA FOR
NEUTROPHILELASTASE-DERIVED LUBRICIN FRAGMENT: A POTENTIAL
BIOMARKER OF EARLY ARTICULAR CARTILAGEDEGRADATION
Y.He1,Q. Liu 2,Q. Zheng 2, B.Wang 1,M.A. Karsdal 1, A.-C. Bay-Jensen 1.1Nordic
BioSci. A/S, Herlev, DENMARK; 2Nordic BioSci. China, Beijing, China
